Newsroom
보로노이, 美오릭에 폐암 치료제 7200억 기술수출
EGFR/HER2 Exon20 ins. 돌연변이 폐암 및 고형암 치료 뇌 전이암까지도 치료 가능한 정밀 표적신약 美 나스닥 상장사 ORIC에 7200억원 기술이전
Pipeline
VRN07, EGFR exon 20 insertion. Non-Small Cell Lung Cancer
Voronoi’s VRN07 program aims to treat NSCLC by targeting EGFR exon 20 insertion. Voronoi aims to also overcome brain metastasis by developing brain-permeable compound.
People
Molecular Modeling: a Foundation for Efficient Drug Development
A breakthrough technology that transformed the existing random and intuitive method, by making the targets and candidates for new drugs visually understandable.
People
Introducing Voronoi Bio
Dr. Son has developed compounds licensed out to global pharmaceuticals, and now introduces Voronoi Bio.
People
Developing Next-Gen Innovative Drugs
We develop first-in-class and best-in-class global innovative drugs.
